The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...

As brain tumors grow, they must do one of two things: push against the brain or use finger-like extensions to invade and ...

As brain tumors grow, they must do one of two things: push against the brain or use finger-like extensions to invade and ...

Trained on multi-hospital data, iSeg spots moving tumors doctors sometimes miss, edging radiation treatment toward pinpoint ...

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

Early imaging and specialist evaluation are crucial when treatment ... stabbing facial pain often mistaken for sinus headache or pressure. Nasopharyngeal cancer slowly blocking sinus drainage: Growing ...

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and CD70 ...

Penpulimab-kcqx, a humanized immunoglobulin G1 monoclonal antibody, blocks the interaction between the programmed death 1 receptor on T-cells and programmed death ligand 1 and 2 on tumor cells.

This randomised, single-centre, double-blind, placebo-controlled, phase 2 trial was conducted at Sun Yat-sen University Cancer Centre in Guangzhou, China. Adult patients (aged 18–65 years) with newly ...

The adjuvant therapy camrelizumab increased the 3-year event-free survival (EFS) rate vs standard of care from 77.3% to 86.9%, translating to a 44% reduced risk of death or relapse in patients with ...